BDBM307590 (4-(2H-1,2,3-triazol-2- yl)thiophen-3-yl)((2R,4R)-4-((4- (difluoromethyl)pyridin-2- yl)amino)-2-methylpyrrolidin-1- yl)methanone::US10150751, Example 28

SMILES C[C@@H]1C[C@H](CN1C(=O)c1cscc1-n1nccn1)Nc1cc(ccn1)C(F)F

InChI Key InChIKey=ZJSKRIMINZOBOT-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 307590   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM307590(US10150751, Example 28 | (4-(2H-1,2,3-triazol-2- y...)
Affinity DataIC50: 102nMAssay Description: All reagents were from GIBCO-Invitrogen Corp. The seeded plates are incubated overnight at 37° C. and 5% CO2. Ala-6,12 human orexin-A as the agonist...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM307590(US10150751, Example 28 | (4-(2H-1,2,3-triazol-2- y...)
Affinity DataIC50: 1.00E+4nMAssay Description: All reagents were from GIBCO-Invitrogen Corp. The seeded plates are incubated overnight at 37° C. and 5% CO2. Ala-6,12 human orexin-A as the agonist...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent